bevacizumab
Commercial- Indications
- Colorectal cancer, Lung cancer
Company intelligence / Profile preview
Samarth Life Sciences has an extensive commercial portfolio across multiple therapeutic areas including critical care drugs. It has established manufacturing capabilities in India with global exports to over seventy countries. The company continues to expand into biotechnology with new facilities planned for anticancer products and biosimilars using recombinant DNA technology. No detailed clinical trial results are published but the company’s marketed products indicate successful regulatory approvals in several regions.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Samarth Life Sciences.